The pharmaceutical industry in the Netherlands is very concerned about the ‘high import rates’ of medicines from Europe that the US President Trump announced earlier this week. “It is no longer obvious that innovative treatments remain available to European patients,” said Carla Vos, general manager of the Innovative Medicines Association (VIG).
ttn-2
Drug manufacturers delivered to announced levies: ‘Patients should not be the victims’
Bytaketonews
Apr 9, 2025